Preliminary results of ZG005, a bispecific antibody targeting PD-1 and TIGIT, as monotherapy in patients with advanced cervical cancer.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hanmei Lou, Shuxia Cheng, Xiaoli Chai, Yun Yan Zhang, Jianhua Shi, Xiumin Li, Lihua Wu, Yisheng Huang, Shihai Liao, Ying Cheng, Yan Yu, Lei Yang, Zhixiang Zhuang, Ou Jiang, Jin Xia, Qinhong Zheng, Shuhuai Niu, Qin Xu, Yili Wang, Jason Jisheng Wu
Institutions: Zhejiang Cancer Hospital, Henan Cancer Hospital, Harbin Medical University, Guangdong Medical College, Jilin Province Tumor Hospital, Third Affiliated Hospital of Harbin Medical University, Nantong Tumor Hospital, Second Affiliated Hospital of Soochow University, Anyang Tumor Hospital, Quzhou City People's Hospital, Fourth Hospital of Hebei Medical University, Fujian Provincial Cancer Hospital, Gannan Medical University, First Affiliated Hospital of Gannan Medical University, Suzhou Zelgen Biopharmaceuticals Co., Ltd. (China)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410812480